Press Room

2016

General Session Highlights Announced for 11th Annual Cardiometabolic Health Congress

Boston, August 17, 2016 - The Cardiometabolic Health Congress has announced General Session Highlights for the 11th Annual CMHC, taking place October 5-8, 2016, at the Sheraton in Boston, MA. Each year, the CMHC provides a one-of-a-kind opportunity for healthcare professionals to stay informed on the latest scientific and clinical developments in the overlapping disease areas of cardiovascular and metabolic disease through a comprehensive and integrated agenda.


FOR IMMEDIATE RELEASE

Contact: Christie Garcia
Tel.: 877-571-4700
E-mail: info@cardiometabolichealth.org

Boston, August 17, 2016 - The Cardiometabolic Health Congress has announced General Session Highlights for the 11th Annual CMHC, taking place October 5-8, 2016, at the Sheraton in Boston, MA. Each year, the CMHC provides a one-of-a-kind opportunity for healthcare professionals to stay informed on the latest scientific and clinical developments in the overlapping disease areas of cardiovascular and metabolic disease through a comprehensive and integrated agenda.

Session I, taking place on Thursday, October 6, focuses on Dyslipidemia, Atherosclerosis and Cardiovascular Disease, and includes presentations and discussion on late-breaking clinical trials and updates from the FDA; a Keynote presentation by Dr. Peter Libby on the increasing prevalence of cardiovascular risk factors, specifically, triglycerides; and the latest in lipid-modifying and antithrombotic therapies.

On Friday, October 7, Hypertension, Cardio-Renal, and Heart Failure comprise Session II, with the recent SPRINT trial, the results of which left clinicians with many unanswered questions, providing the basis for many of the presentations. Session II will include a Keynote from Dr. Suzanne Oparil, one of SPRINT’s principal investigators; patient case discussions; a presentation by Dr. Clyde Yancy on heart failure in the context of SPRINT; and an examination of SGLT2 inhibitors as second-line therapy. Later that day, Diabetes Management takes the stage in Session III. Keynote speaker Dr. C. Ronald Kahn will discuss the gut microbiome as a modifier of insulin resistance and metabolic syndrome; results of CV outcomes trials and diabetes therapies, the implications of recent trials on the management of diabetes, and future directions of insulin and non-insulin therapies alike will be discussed.

The 11th Annual CMHC will conclude Saturday, October 8 with Session IV, which will cover Obesity, Lifestyle Management, and Cardiovascular Disease. Dr. Subodh Verma will present a Keynote on obesity fat distribution and cardiovascular risk; Drs. Lee Kaplan and Francesco Rubino will discuss the newest evidence on metabolic surgery; and Dr. Caroline Apovian will present the latest on obesity treatments and pharmacology guidelines for clinicians.

For a complete list of speakers, agenda, and registration details for the 11th Annual Cardiometabolic Health Congress visit: http://www.cardiometabolichealth.org/2016/index.html or call 877-571-4700.

Cardiometabolic Health Congress Holds Successful Primary-Care Focused Best of the CMHC Regional Conference Series

Chicago, June 21, 2016 - Built on the reputation and first-rate education offered at the annual CMHC in Boston, more than 100 primary care physicians and healthcare professionals attended the second Best of the CMHC series this past Saturday, June 18, 2016 in Chicago, IL. Consisting of live, focused, interactive educational sessions in a convenient 1-day format the conference provided: Read More


FOR IMMEDIATE RELEASE

Contact: Christie Garcia
Tel.: 877-571-4700
E-mail: info@cardiometabolichealth.org

Chicago, June 21, 2016 - Built on the reputation and first-rate education offered at the annual CMHC in Boston, more than 100 primary care physicians and healthcare professionals attended the second Best of the CMHC series this past Saturday, June 18, 2016 in Chicago, IL. Consisting of live, focused, interactive educational sessions in a convenient 1-day format the conference provided:

The conference’s intimate audience size facilitated a higher level of interaction among participants and faculty. “It has been a significant privilege to be a speaker at the CMHC meetings. I have learned a great deal from the other faculty members and from the audiences' insightful questions and comments,” Lawrence Blonde, MD, who delivered presentations at both Chicago and Atlanta Best of the CMHC series said. Speaker Peter H. Jones, MD, said, “The smaller group size allows local/regional healthcare providers to have greater faculty contact, to have their questions answered after the lectures, and have time to connect with colleagues.”

  • updates on current, new, and emerging therapies
  • recommended guidelines
  • clinical strategies to individualize care and empower patients to reduce global cardiometabolic risk and improve clinical outcomes.

More than one-third of the US population has at least one cardiometabolic disorder such as diabetes, dyslipidemia, obesity, or hypertension, with an ever-increasing presence that continues to create major challenges for healthcare providers. Employing aggressive strategies for early identification and comprehensive management of patients presenting with multiple cardiometabolic risk factors is key to stemming the future burden of cardiovascular and metabolic disease. Visit the Cardiometabolic Health Congress website @cardiometabolichealth.org, for more information on CMHC live conferences, a free online CME-CE library, news, and clinician resources.

Press Room Archive